[Skip to Navigation]
Views 4,281
Citations 0
Observation
June 17, 2020

Bendamustine Monotherapy for Primary Cutaneous Gamma-Delta T-Cell Lymphoma

Author Affiliations
  • 1Department of Dermatology, Venereology, and Allergology, HELIOS St Elisabeth Hospital Oberhausen, University Witten/Herdecke, Oberhausen, Germany
  • 2Institute of Pathology, Mülheim an der Ruhr, Germany
  • 3Department of Dermatology, HELIOS Hospital Krefeld, Krefeld, Germany
  • 4Dermatopathology Research Unit, Department of Dermatology, Medical University of Graz, Graz, Austria
JAMA Dermatol. 2020;156(10):1140-1142. doi:10.1001/jamadermatol.2020.1231
Add or change institution
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×